Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP) (French, HTML)

View metadata and access the original French HTML file: Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP).

Format

HTML

Access

file-only

Publisher-reported update

2021-12-29

Drugs are authorized for sale in Canada once they have successfully gone through the drug review process, which includes the assessment of the safety, efficacy and quality of the drug. However, Health Canada's SAP allows practitioners to request access to drugs that are not available in Canada for the emergency treatment of patients with serious or life-threatening conditions who have exhausted other treatment options.

Access original file